Location History:
- Dobriv, CZ (2015)
- Hostivice, CZ (2018 - 2023)
Company Filing History:
Years Active: 2015-2023
Title: The Innovations of Ondrej Dammer: A Pharmaceutical Pioneer
Introduction
Ondrej Dammer, an inventive force hailing from Hostivice, Czech Republic, has made significant contributions to the pharmaceutical industry with a total of five registered patents. His innovative spirit is evident in the groundbreaking compositions he has developed, which showcase his expertise in drug formulation and design.
Latest Patents
Among his latest patents is a pharmaceutical composition that combines rosuvastatin and ezetimibe. The invention encompasses a unique preparation method for this composition, utilizing the active ingredients rosuvastatin and ezetimibe. The weight ratio of these components, ranging from 1:2 to 2:1, demonstrates a balance aimed at enhancing therapeutic efficacy. Another notable patent pertains to crystalline modifications of methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}phenyl)amino](phenyl)methylidene}-2-oxo-2,3-dihydro-1H-indole-6-carboxylate salts. This patent details not only the compounds but also the processes for their preparation, thereby providing a foundation for future pharmaceutical applications.
Career Highlights
Throughout his career, Dammer has been associated with prominent companies within the pharmaceutical sector, including Zentiva and Sanofi. His role in these organizations has allowed him to hone his skills and contribute to the development of innovative pharmaceutical solutions. His commitment to advancing medication efficacy is reflected in the patents he has secured.
Collaborations
Dammer has had the opportunity to collaborate with various professionals in the field. Notably, he has worked alongside esteemed colleagues such as Jindrich Richter and Gary James Miller. These collaborations have undoubtedly played a vital role in enhancing the quality and impact of his inventions.
Conclusion
Ondrej Dammer's journey as an inventor exemplifies dedication and innovation in the pharmaceutical realm. With his recent patents showcasing advancements in drug compositions and preparation methods, he continues to push the boundaries of medical science. His contributions not only reflect his personal commitment to healthcare improvement but also emphasize the collaborative spirit of the industry he represents.